(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CLOZARIL

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

CLOZARIL

ST13

US500000073394129

Class

5

Filing

73394129

Registration

1265560

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

28

Latest update

04/04/2024

Trademark type

Word

Nice classes

5

Filing date

09/29/1982

Registration date

01/31/1984

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/04/2024

Last transaction

04/04/2024

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

08/26/1982

First use in commerce

08/26/1982

Drawing code

1

Owner type

03

Owner location

Basel, CH

Law office

570

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

NOVARTIS AG
Sandoz, Inc.

Representatives

Maury M. Tepper, III Tepper & Eyster, PLLC

Technical classification

Nice Classes

Class 5

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

a Neuroleptic Indicated for the Management of Manifestations of Acute and Chronic Psychotic Disorders

Publications

History of USPTO decisions and trademark events.

28 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

04/04/2024

RNL3

REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

04/04/2024

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

04/04/2024

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/04/2024

E89R

TEAS SECTION 8 & 9 RECEIVED

11/16/2023

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

01/31/2023

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

12/14/2013

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

12/14/2013

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

12/14/2013

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

12/14/2013

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

12/06/2013

E89R

TEAS SECTION 8 & 9 RECEIVED

12/06/2013

CORV

REVIEW OF CORRESPONDENCE COMPLETE

09/29/2009

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/21/2009

CFIT

CASE FILE IN TICRS

05/09/2008

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/19/2004

MAIL

PAPER RECEIVED

12/06/2004

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

03/04/2004

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

03/04/2004

89AF

REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED

01/14/2004

E89R

TEAS SECTION 8 & 9 RECEIVED

01/14/2004

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

05/30/1990

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

01/25/1990

R.PR

REGISTERED-PRINCIPAL REGISTER

01/31/1984

PUBO

PUBLISHED FOR OPPOSITION

11/08/1983

NPUB

NOTICE OF PUBLICATION

09/21/1983

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

08/22/1983

DOCK

ASSIGNED TO EXAMINER

06/24/1983

Continuous trademark protection

Get notified about every new filing that threatens CLOZARIL or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.